[IgA dominates the early neutralizing antibody response to SARS-CoV-2 virus]

Med Sci (Paris). 2021 Nov;37(11):968-970. doi: 10.1051/medsci/2021154. Epub 2021 Dec 1.
[Article in French]
No abstract available

Publication types

  • News
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / immunology*
  • COVID-19* / immunology
  • Humans
  • Immunoglobulin A / immunology*
  • SARS-CoV-2

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Immunoglobulin A

Grants and funding